FindTrial
Sign In

Glutaminergic Agents for Cocaine Abuse - 5

Glutaminergic Agents for Cocaine Abuse

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000280
Enrollment
0
Registered
1999-09-21
Start date
1994-09-30
Completion date
1999-08-31
Last updated
2017-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders

Keywords

cocaine

Brief summary

The purpose of this study is to evaluate glutaminergic agents for cocaine abuse.

Interventions

DRUGNimodipine

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
VA Connecticut Healthcare System
CollaboratorFED
Yale University
Lead SponsorOTHER

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

Please contact site for information.

Design outcomes

Primary

MeasureTime frame
Cocaine effects—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026